Key result
Treatment by a surgeon with 250 versus 10 prior radical prostatectomies was associated with an absolute risk reduction for biochemical recurrence of 6.6%, 12.0%, and 9.7% in low, medium, and high-risk patients.
Why the study?
Does surgeon experience reduce biochemical recurrence in patients with prostate cancer undergoing open radical prostatectomy across all preoperative risk categories?
Cohort (n=7,683)
Does surgeon experience reduce biochemical recurrence in patients with prostate cancer undergoing open radical prostatectomy across all preoperative risk categories?
Cancer control after radical prostatectomy improves with increasing surgeon experience irrespective of patient risk, suggesting inadequate surgical technique is a primary reason for recurrence in low-risk patients.
Answers are grounded in this paper and cite their sources.
Higher surgeon volume may reduce biochemical recurrence across risk groups; extends volume-outcome data but remains hypothesis-generating.
PURPOSE: We have previously reported that there is a learning curve for open radical prostatectomy. In the current study we determined whether the effects of the learning curve are modified by patient risk, as defined by preoperative tumor characteristics. MATERIALS AND METHODS: The study included 7,683 eligible patients with prostate cancer treated with open radical prostatectomy by 1 of 72 surgeons. Surgeon experience was coded as the total prior number of radical prostatectomies done by the surgeon before a patient surgery. Multivariate survival time regression models were used to evaluate the association between surgeon experience and biochemical recurrence separately in each preoperative risk group. RESULTS: We saw no evidence that patient risk affected the learning curve. There was a statistically significant association between biochemical recurrence and surgeon experience on all analyses. The absolute risk difference in a patient receiving treatment from a surgeon with 10 vs 250 prior radical prostatectomies was 6.6% (95% CI 3.4-10.3), 12.0% (95% CI 6.9-18.2) and 9.7% (95% CI 1.2-18.2) in patients at low, medium and high preoperative risk. Recurrence-free probability in patients with low risk disease approached 100% for the most experienced surgeons. CONCLUSIONS: Cancer control after radical prostatectomy improves with increasing surgeon experience irrespective of patient risk. Excellent rates of cancer control in patients with low risk disease treated by the most experienced surgeons suggest that the primary reason that recurrence develops in such patients is inadequate surgical technique. The results have significant implications for clinical care.
No takes yet. Share an insight, caveat, or question.
Klein et al. (2008) conducted a cohort in Prostate cancer (n=7,683). High surgeon experience (250 prior radical prostatectomies) vs. Low surgeon experience (10 prior radical prostatectomies) was evaluated on Biochemical recurrence (Absolute risk difference 6.6% (low risk patients), 95% CI 3.4-10.3). Treatment by a surgeon with 250 versus 10 prior radical prostatectomies was associated with an absolute risk reduction for biochemical recurrence of 6.6%, 12.0%, and 9.7% in low, medium, and high-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: